NCT07735715Recruiting
HOBSCOTCH-YOUTH and Young Adults
Source: ClinicalTrials.gov · Last updated 2 Nov 2026
Brief summary (registry, in English)
The goal of this clinical trial is to learn more about the home-based epilepsy self-management program, HOBSCOTCH, for improving cognitive function (thinking and memory) and quality of life specifically in young adults, ages 18 - 29 years, who have epilepsy. It will also learn if a modification of the program for youth with epilepsy, ages 13 - 17, improves thinking and memory and quality of life and reduces stress for their parents. Researchers will enroll 260 young adults with epilepsy and 40 youth with epilepsy and their parent or guardian. Researchers will compare responses to questionnaires and surveys before and after participation in the HOBSCOTCH program to see if thinking, memory and quality of life have improved for young adults and youth with epilepsy and to see if parents have improved quality of life as well. Participants will: * Attend 9 weekly one-hour sessions of the HOBSCOTH program in their homes with a one-on-one coach using their computer or their phone; youth with epilepsy (ages 13 - 17) will attend alongside a parent or legal guardian. * Keep a short daily diary about their seizures and activity in the program using a smart phone app(lication) * Complete surveys and questionnaires before HOBSCOTCH and 3 months and 6 months later. There are no study visits to a medical center. HOBSCOTCH is a virtual or telehealth intervention.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- First submitted
- 24 Jul 2026
- Start date
- 1 Sept 2026
- Primary completion date
- 1 May 2029
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- Diseases
- Epilepsy
- NCT number
- NCT07735715
What you commit to
- Study type: Interventional
- Planned participants: 300
- From 1 Sept 2026 to the primary completion date, 1 May 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Active psychosis (any participant)
- Illicit substance abuse (any participant)
- Severe cognitive/intellectual disability (any participant)
- YWE cannot participate without a parent and parent's consent (or legal guardian)
- YWE cannot participate without assent even if a parent or legal guardian gives consent
Who the study is looking for
- Inclusion Criteria for Young Adults with Epilepsy (YAWE) and Youth with Epilepsy (YWE):
- Age 18 - 29 years for YAWE
- Age 13 - 17 years for YWE
- For YWE at least one parent or legal guardian provides consent and agrees to participate
- Diagnosis of epilepsy (controlled or uncontrolled seizures)
- Subjective cognitive complaints (memory, attention, learning, problem solving, executive function, planning)
- Literate and proficient in English
- Telephone access
- Internet Access.
- Parent or legal guardian of a youth with epilepsy (age 13 - 17 years)
- Literate and proficient in English
- Telephone access
- Internet Access
Age in the registry: 13 years to 29 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dartmouth Hitchcock Coordinator of this site? Confirm its status | Lebanon | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.